The 3 analysts offering 12-month price forecasts for Amphastar Pharmaceuticals Inc have a median target of 70.00, with a high estimate of 71.00 and a low estimate of 66.00. The median estimate represents a +52.31% increase from the last price of 45.96.
The current consensus among 4 polled investment analysts is to Buy stock in Amphastar Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.69
Reporting Date Nov 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.